Revenue from operations₹22.89 Cr
Q1 FY27VAISHALI · What Changed
What Changed at
Vaishali Pharma Limited?
See reported financial changes and material NSE disclosures for Vaishali Pharma Limited.
My CompaniesSaved on this device. No account needed.
Follow a company to build your personal change feed.
Latest company changes
Vaishali Pharma Limited
Start with what changed, then open the supporting financial and operating detail only when you need it.
Financial snapshot
Latest Reported Financials
Available reported figures from the latest period.
Total income₹23.47 Cr
Q1 FY27Profit after tax₹1.55 Cr
Q1 FY27EPS₹0.12
Q1 FY27Profit before tax₹1.73 Cr
Q1 FY27Supporting financial context
Margins and Supporting Figures
Only reported or directly calculated figures that are available for this company.
PAT margin6.75%
Profit before tax₹1.73 Cr
Finance cost₹0.20 Cr
Depreciation₹0.14 Cr
Tax₹0.24 Cr
Financial trends
Recent Reported Financial Trends
Comparable periods stay separated; unavailable periods are not filled or estimated.
- First Quarter Ended 30th June, 2026₹22.89 Cr
- Quarter Ended March 31, 2026₹26.93 Cr
- First Quarter Ended 30th June, 2026₹23.47 Cr
- Quarter Ended March 31, 2026₹28.19 Cr
- First Quarter Ended 30th June, 2026₹1.55 Cr
- Quarter Ended March 31, 2026₹0.38 Cr
- First Quarter Ended 30th June, 2026₹0.12
- Quarter Ended March 31, 2026₹0.03
Today
Loading today’s changes…Today on Nivata
— meaningful changes— companies
Checking the latest tracked company developments…